메뉴 건너뛰기




Volumn 4, Issue 5, 2003, Pages 423-459

Drug metabolism and drug interactions: Application and clinical value of in vitro models

Author keywords

[No Author keywords available]

Indexed keywords

2,8 DIMETHYL 3 METHYLENE 1 OXA 8 AZASPIRO[4.5]DECANE; 6 CHLORO 4 CYCLOPROPYL 3,4 DIHYDRO 4 [(2 PYRIDYL)ETHYNYL] 2(1H) QUINAZOLINONE; AGOMELATINE; ALMOKALANT; ALPRAZOLAM; BOSENTAN; CLARITHROMYCIN; CYTOCHROME P450; EZLOPITANT; FELODIPINE; FLUCONAZOLE; HYDRODOLASETRON; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INDINAVIR; KETOCONAZOLE; LOXTIDINE; METOPROLOL; MIDAZOLAM; MOFAROTENE; N,N DIETHYL N' (1 ETHYL 6 METHYL 8ALPHA ERGOLINYL)SULFAMIDE; PAROXETINE; SIMVASTATIN; SOLVENT; THEOPHYLLINE; TOLBUTAMIDE; TRAZODONE; TRIAZOLAM; UNINDEXED DRUG; VERAPAMIL; WARFARIN;

EID: 0142010701     PISSN: 13892002     EISSN: None     Source Type: Journal    
DOI: 10.2174/1389200033489361     Document Type: Review
Times cited : (147)

References (334)
  • 1
    • 0032428779 scopus 로고    scopus 로고
    • Clarke, S. E. (1998) Xenobiotica, 28(12), 1167-202.
    • (1998) Xenobiotica , vol.28 , Issue.12 , pp. 1167-1202
    • Clarke, S.E.1
  • 132
    • 0033061072 scopus 로고    scopus 로고
    • Mechanism-based, inactivation, of, cytochrome, P-450-3A4, by, mifepristone, (RU486)
    • He, K.; Woolf, T. F. and Hollenberg, P. F. Mechanism-based, inactivation, of, cytochrome, P-450-3A4, by, mifepristone, (RU486) (1999) J. Pharmacol. Exp. Ther., 288(2), 791-7.
    • (1999) J. Pharmacol. Exp. Ther. , vol.288 , Issue.2 , pp. 791-797
    • He, K.1    Woolf, T.F.2    Hollenberg, P.F.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.